InMed Pharmaceuticals Inc. (MTRI) stock
MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
$17.50−2.37 (-11.93%)
Close on Nov 17, 2026Market cap $96.14MP/E –Yield –
InMed Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
InMed Pharmaceuticals's price to book ratio was 8.3× on Nov 3, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.1× to 8.3×, with a median of 0.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 3, 2026 | 8.3× | +8.1 |
| 2025 | Dec 31, 2025 | 0.2× | −0.1 |
| 2024 | Dec 31, 2024 | 0.4× | +0.2 |
| 2023 | Oct 31, 2023 | 0.1× | −0.0 |
| 2022 | Dec 30, 2022 | 0.2× | −0.7 |
| 2021 | Dec 31, 2021 | 0.9× | −2.9 |
| 2020 | Dec 31, 2020 | 3.8× | – |
See a number that looks wrong?